US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -26.77%58.48K | 15.39%82.13K | -28.13%279.89K | 1.61%65.56K | -18.27%63.29K | -39.02%79.86K | -38.91%71.18K | -65.67%389.43K | -70.55%64.52K | -48.84%77.44K |
Selling and administrative expenses | -54.77%24.71K | 104.23%44.03K | -30.03%133.43K | 9.35%29.73K | -25.44%27.5K | -38.17%54.64K | -43.62%21.56K | -70.08%190.69K | -58.83%27.19K | -42.83%36.88K |
-General and administrative expense | -54.77%24.71K | 104.23%44.03K | -30.03%133.43K | 9.35%29.73K | -25.44%27.5K | -38.17%54.64K | -43.62%21.56K | -70.08%190.69K | -58.83%27.19K | -42.83%36.88K |
Research and development costs | --0 | ---- | -77.73%8.67K | -59.80%197 | -65.21%1.23K | -78.73%7.25K | ---- | -61.95%38.94K | -98.92%490 | -77.91%3.54K |
Other operating expenses | 87.86%33.76K | -23.21%38.1K | -13.78%137.78K | -3.29%35.63K | -6.64%34.56K | 110.98%17.97K | -35.91%49.62K | -59.51%159.8K | -65.72%36.84K | -47.74%37.02K |
Operating profit | 26.77%-58.48K | -15.39%-82.13K | 28.13%-279.89K | -1.61%-65.56K | 18.27%-63.29K | 39.02%-79.86K | 38.91%-71.18K | 65.16%-389.43K | 70.55%-64.52K | 48.84%-77.44K |
Net non-operating interest income (expenses) | ||||||||||
Other net income (expenses) | 5.41K | |||||||||
Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.41K | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.41K | ---- | ---- |
Income before tax | 26.77%-58.48K | -15.39%-82.13K | 27.12%-279.89K | -10.90%-65.56K | 18.27%-63.29K | 39.02%-79.86K | 38.91%-71.18K | 65.64%-384.02K | 73.02%-59.12K | 48.84%-77.44K |
Income tax | 0 | 0 | ||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 26.77%-58.48K | -15.39%-82.13K | 27.12%-279.89K | -10.90%-65.56K | 18.27%-63.29K | 39.02%-79.86K | 38.91%-71.18K | 65.67%-384.02K | 73.02%-59.12K | 48.84%-77.44K |
Net income continuous operations | 26.77%-58.48K | -15.39%-82.13K | 27.12%-279.89K | -10.90%-65.56K | 18.27%-63.29K | 39.02%-79.86K | 38.91%-71.18K | 65.67%-384.02K | 73.02%-59.12K | 48.84%-77.44K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 26.77%-58.48K | -15.39%-82.13K | 27.12%-279.89K | -10.90%-65.56K | 18.27%-63.29K | 39.02%-79.86K | 38.91%-71.18K | 65.67%-384.02K | 73.02%-59.12K | 48.84%-77.44K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 26.77%-58.48K | -15.39%-82.13K | 27.12%-279.89K | -10.90%-65.56K | 18.27%-63.29K | 39.02%-79.86K | 38.91%-71.18K | 65.67%-384.02K | 73.02%-59.12K | 48.84%-77.44K |
Diluted earnings per share | 26.79%-0.0027 | -15.38%-0.0038 | 50.00%-0.01 | 0 | 18.26%-0.003 | 62.78%-0.0037 | 66.83%-0.0033 | 66.67%-0.02 | 0 | 63.91%-0.0036 |
Basic earnings per share | 26.79%-0.0027 | -15.38%-0.0038 | 50.00%-0.01 | 0 | 18.26%-0.003 | 62.78%-0.0037 | 66.83%-0.0033 | 66.67%-0.02 | 0 | 63.91%-0.0036 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.